myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions about neoantigen discovery. Additionally, we’re pleased to announce that our CEO, Cedric, received the Medical Genetics award at the Vexillum Sciacca Awards in the Vatican. Always great to receive extra recognition for the work we have been doing as a strong team!
TCD Capital is a fund manager based in Brussels and Antwerp investing in Scale-Ups primarily in Smart Living, Tech, and Life Sciences.
We seek to customise the content to the segments we serve.
These are both fund investors and the entrepreneurs with whom we have created alliances.
We are happy to keep in touch.